Risk of cancer in patients with myasthenia gravis

Annals of the New York Academy of Sciences

Volumn 841, Issue , 1998, Pages 742-745

  Evoli, A ^a   Batocchi, A P ^a   Tonali, P ^a   Marciano, M ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

AGED; CANCER; CANCER RISK; CHILD; CONFERENCE PAPER; CORTICOSTEROID THERAPY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; RISK ASSESSMENT; THYMECTOMY; THYMOMA;

EID: 0031950063     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb11011.x     Document Type: Conference Paper

References (11)

1. EVOLI, A. et al. 1992. Long-term results of corticosteroid therapy in patients with myasthenia gravis. Eur. Neurol. 32: 37-43.
2. OOSTERHUIS, H. J. G. H. 1984. Myasthenia Gravis. Churchill Livingstone. Edinburgh.
3. PENN, I. 1990. Cancer complicating organ transplantation. N. Engl. J. Med. 323: 1767-1769.
4. CONFAVREUX, C. et al. 1996. Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study. Neurology 46: 1607-1612.
5. DEEG, H. J. et al. 1996. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood 87: 386-392.
6. PAPATESTAS, A. E. et al. 1971. The relationship between thymus and oncogenesis: a study of incidence of non-thymic malignancy in myasthenia gravis. Br. J. Cancer 25: 635-645.
7. GOULON, M. et al. 1980. Myasthenia gravis and associated diseases. Int. J. Neurol. 14: 61-72.
8. MONDEN, Y. et al. 1991. Extrathymic malignancy in patients with myasthenia gravis. Eur. J. Cancer 27: 745-747.
9. MASAOKA, A. et al. 1994. Thymectomy and malignancy. Eur. J. Cardiothorac. Surg. 8: 251-253.
10. ELLISON, G. W. et al. 1989. A placebo-controlled, randomized, double-masked, variable dosage, clinical trial of azathioprine with and without prednisolone in multiple sclerosis. Neurology 39: 1018-1026.
11. DRACHMAN, D. B. 1996. Immunotherapy in neuromuscular disorders: current and future strategies. Muscle Nerve 19: 1239-1251.